Fingerprint
Dive into the research topics of 'An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
An open-label, multicenter, phase II study of bevacizumab for the treatment of angiosarcoma and epithelioid hemangioendotheliomas
M. Agulnik, J. L. Yarber, S. H. Okuno, M. von Mehren, B. D. Jovanovic, B. E. Brockstein, A. M. Evens, R. S. Benjamin
Research output: Contribution to journal › Article › peer-review
214
Scopus
citations